Fort Point Capital Partners LLC
Source: SEC Form 13F · as of Mar 2026Fort Point Capital Partners LLC holds 12 biotech & pharma companies tracked by BioSniper, totaling $7.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
12
Total value held
$7.0M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 6,906 | $1.5M |
| AMGNAMGEN INC | 2,554 | $899K |
| MRKMerck & Co., Inc. | 6,908 | $837K |
| JNJJOHNSON & JOHNSON | 3,064 | $749K |
| ABTABBOTT LABORATORIES | 5,753 | $591K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 2,157 | $584K |
| GILDGILEAD SCIENCES, INC. | 3,320 | $463K |
| BMYBRISTOL MYERS SQUIBB CO | 6,602 | $400K |
| LLYELI LILLY & Co | 363 | $334K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 593 | $265K |
| ELVElevance Health Inc. | 752 | $220K |
| PFEPFIZER INC | 7,181 | $202K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.